# A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease

> **NCT04867642** · PHASE1 · COMPLETED · sponsor: **UCB Biopharma SRL** · enrollment: 100 (actual)

## Conditions studied

- Healthy Study Participants
- Parkinson's Disease

## Interventions

- **DRUG:** UCB0022
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04867642
- **Lead sponsor:** UCB Biopharma SRL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-29
- **Primary completion:** 2023-02-27
- **Final completion:** 2023-02-27
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867642, "A Study to Test the Safety, Tolerability, and Blood Levels of UCB0022 in Healthy Participants and Participants With Parkinson's Disease". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04867642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*